1[1]Serby J V, Friedman GD, Quesenberry CP Jr, et al. Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries[J]. Am J Epidemiol, 1990, 131:1017～1027.
2[2]Frohlich ED. Uric acid: a risk factor for coronary heart disease [J]. JAMA, 1993, 270:378～379.
3[3]Tuomilehto J, Zimmer P, Wolfe, et al. Plasma uric acid level and its association with diabetes mellitus and some biological parameters in abiracial population of Figi[J]. Am J Epidemiol, 1998, 127:321～336.
4[4]Oham K, Klag MJ, Sakai Y, et al. Factors associated with high density lipoprotein cholesterol in Japanese and American telephone executiues[J]. Am J Epidemiol, 1991, 134:137～148.
5[5]Brand FN, McGee DL, Kannel WB, et al. Hyperuricemia as a risk factor of coronary heart disease: the Framingham study[J]. AmJ Epidemiol, 1985, 121:11～18.
6[6]Irbarren C, Folsom AR, Eckfaloft JH, et al. Correlation of uric acid and its association with asymptomatic carotid atherosclerosis: the aric study[J]. Ann Epidemiol, 1996, 6:331～340.
7Descheeder IK,van de Kraay Am,Lameses JM,et al. Myocardiol malodialdehyde and uric acid release after short - lasting coronary occlusions during angioplasty: Potential mechanisms for free radical generation. Am J Cardiol, 1991;68:392～ 395
8Gertler Mm, Gam Sm, Levine SA. Serum uric acid in relation to age and physique in health and in coronary heart disease. Ann Intern Med,1951;34:1421 - 1431
9Levine W, Dyer AR, Shekelle RB, et al. Serum uric acid and 11.5 -year mortality of middle - aged: findings of the Chicago Heart Association Detection project in Industry. J Clin Epidemiol, 1989;42:257- 267
10Brand FN, Megee DL, Kannct, et al. Hyperuricenmia as a risk of coronary heart disease:the Framingham study. Am J Epidemiol, 1985; 121:11- 18
4MARKOVA L I,KUZNETSOVA I V,KORENKOV V V,et al.The state of hemodynamics and microcirculation in patients with hypertensive disease during long term controlled therapy with lisinopril[J].Kardiologiia,2003,43(12):47-50.
5SOFFER B,ZHANG Z,MILLER K,et al.A double-blind,placebo-controlled,dose-response study of the effectiveness and safety of lisinopril for children with hypertension[J].Am J Hypertens,2003,16(10):795-800.
6BORGHI C,AMBROSIONI E.Double-blind comparison between zofenopril and lisinopril in patients with acute myocardial infarction:results of the Survival of Myocardial Infarction Long-term Evaluation-2 (SMILE-2) study[J].Am Heart J,2003,145(1):80-87.
7SENGUL A M,ALTUNTAS Y,KURKLU A,et al.Beneficial effect of lisinopril plus telmisartan in patients with type 2 diabetes,microalbuminuria and hypertension[J].Diabetes Res Clin Pract,2006,71(2):210-219.
8MARKOVA L I,KUZNETSOVA I V,RADZEVICH A E.Lisinopril effects on cerebral blood flow and blood rheology in hypertensive patients[J].Ter Arkh,2004,76(11):41-43.
10WONG G C,MARCOTTE F,RUDSKI L G.Impact of chronic lisinopril therapy on left atrial volume versus dimension in chronic organic mitral regurgitation[J].Can J Cardiol,2006,22(2):125-129.
